Current tx consists of
a pegylated (time released) for
interferon once a week along with twice daily dosing of
ribavirin (Peg-Intron uses weight based dosing <span style = 'background-color: #dae8f4'>for</span>
the riba, Pegasys uses 1200 mg a day <span style = 'background-color: #dae8f4'>for</span>
most) Current "cure/remission" rates are about 85% for
genotypes 2 and 3, and about 50% for
types 1 and 4.
Dr Gary Lee Davis, the author of
the study you quote has a newer one with the new stats, as of
2001 at the following site.